|

Safely Reduce Cystoscopic Evaluations for Hematuria Patients

RECRUITINGN/ASponsored by Erasmus Medical Center
Actively Recruiting
PhaseN/A
SponsorErasmus Medical Center
Started2023-05-31
Est. completion2026-05-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06026189

Summary

The SeARCH-trial assess the clinical impact of a molecular urine test as a 'urine-first' strategy in the diagnostic workup of patients presenting with microscopic hematuria.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Microscopically confirmed microscopic hematuria of voided urine defined as ≥3 erythrocytes per high power field
* Male patients ≥40 years
* Female patients ≥50 years

Exclusion Criteria:

* History of urothelial bladder- or urinary tract cancer
* Presence of macroscopic (visible) hematuria
* Woman who is or may be pregnant

Conditions5

Bladder CancerCancerHematuriaUrothelial CarcinomaUrothelial Neoplasm

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.